Selected Grants
National Career Development Program for Researchers in Pediatric Clinical Pharmacology
Inst. Training Prgm or CMEPrincipal Investigator · Awarded by National Institutes of Health · 2024 - 2028Pharmacokinetic and pharmacodynamic study of montelukast in premature infants with BPD (PRISM)
ResearchPD/PI · Awarded by National Institutes of Health · 2023 - 2028Application of Physiologically-Based Pharmacokinetic Modeling to Characterize Drug-Drug Interactions in Infants
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2023 - 2026Duke-UNC Collaborative Pediatric Clinical Pharmacology Postdoctoral Training Program
Inst. Training Prgm or CMEPreceptor · Awarded by National Institutes of Health · 2021 - 2026Physiologically-Based Pharmacokinetic Modeling to Guide Drug Dosing in Children with Obesity
ResearchPrincipal Investigator · Awarded by University of North Carolina - Chapel Hill · 2018 - 2024External Relationships
- Children's Mercy Kansas City
- Chimerix, Inc.
- Melinta Therapeutics
- Simulations Plus, Inc.
- Tellus Therapeutics, Inc.
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.